Document Detail


Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
MedLine Citation:
PMID:  21715679     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hutchinson-Gilford progeria syndrome (HGPS) is a lethal genetic disorder characterized by premature aging. HGPS is most commonly caused by a de novo single-nucleotide substitution in the lamin A/C gene (LMNA) that partially activates a cryptic splice donor site in exon 11, producing an abnormal lamin A protein termed progerin. Accumulation of progerin in dividing cells adversely affects the integrity of the nuclear scaffold and leads to nuclear blebbing in cultured cells. Progerin is also produced in normal cells, increasing in abundance as senescence approaches. Here, we report the effect of rapamycin, a macrolide antibiotic that has been implicated in slowing cellular and organismal aging, on the cellular phenotypes of HGPS fibroblasts. Treatment with rapamycin abolished nuclear blebbing, delayed the onset of cellular senescence, and enhanced the degradation of progerin in HGPS cells. Rapamycin also decreased the formation of insoluble progerin aggregates and induced clearance through autophagic mechanisms in normal fibroblasts. Our findings suggest an additional mechanism for the beneficial effects of rapamycin on longevity and encourage the hypothesis that rapamycin treatment could provide clinical benefit for children with HGPS.
Authors:
Kan Cao; John J Graziotto; Cecilia D Blair; Joseph R Mazzulli; Michael R Erdos; Dimitri Krainc; Francis S Collins
Related Documents :
18466749 - K+ channels at the axon initial segment dampen near-threshold excitability of neocortic...
21598299 - Ebp50 is involved in the regulation of vascular smooth muscle cell migration and cytoki...
4020509 - Relationship between spatial-frequency and orientation tuning of striate-cortex cells.
21930799 - Telomere shortening alters the kinetics of the dna damage response after ionizing radia...
22455749 - Germline transmission of a novel rat embryonic stem cell line derived from transgenic r...
21696969 - 18β-glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through r...
21558799 - Linking specification to differentiation: from proneural genes to the regulation of cil...
10923279 - Enhancement of human endometrial stromal decidualization by bestatin, an aminopeptidase...
10767689 - A painful cutaneous nodule as the presentation of metastatic transitional cell carcinom...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Science translational medicine     Volume:  3     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-30     Completed Date:  2011-10-25     Revised Date:  2013-01-31    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  89ra58     Citation Subset:  IM    
Affiliation:
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-8004, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibiotics, Antineoplastic / pharmacology*
Autophagy / drug effects
Cell Nucleus / drug effects,  ultrastructure
Cells, Cultured
Fibroblasts / cytology,  drug effects*,  metabolism*
HeLa Cells
Humans
Lamin Type A / genetics,  metabolism
Nuclear Proteins / genetics,  metabolism
Phenotype*
Progeria / metabolism*,  pathology,  physiopathology
Protein Precursors / genetics,  metabolism
Recombinant Fusion Proteins / genetics,  metabolism
Sirolimus / pharmacology*
Grant Support
ID/Acronym/Agency:
R00 AG029761/AG/NIA NIH HHS; R00AG029761/AG/NIA NIH HHS; R01NS051303/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Lamin Type A; 0/Nuclear Proteins; 0/Protein Precursors; 0/Recombinant Fusion Proteins; 0/prelamin A; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human apoE isoforms differentially regulate brain amyloid-? peptide clearance.
Next Document:  Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-...